AKR1B1 inhibition using NARI-29-an Epalrestat analogue-alleviates Doxorubicin-induced cardiotoxicity via modulating Calcium/CaMKII/MuRF-1 axis
Syamprasad NP, Siddhi Jain, Bishal Rajdev, Samir Ranjan Panda, Jagadeesh Kumar Gangasani, Veerabhadra Swamy Challa, Jayathirtha Rao Vaidya, Gopal C. Kundu, V.G.M. Naidu
Topics & Concepts
DoxorubicinCardiotoxicityChemistryPharmacologyMedicineChemotherapyInternal medicineAldose Reductase and TaurineCardiac Ischemia and ReperfusionChemotherapy-induced cardiotoxicity and mitigation